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Abstract—Tissue engineering has progressed to enable devel-
opment of engineered 3D in vitro tissue models that can
recapitulate in vivo cellular physiologies through the control
of an expansive variety of microenvironmental design fea-
tures, including mechanical, extracellular matrix, and soluble
stimulatory cues. Microenviromental cues stimulate cells
through a system of interconnected molecular regulatory
pathways that govern cellular behaviors within engineered
tissue models. Detailed understanding of how cell signaling
pathways process these microenvironmental stimuli to govern
their behaviors will require application of systems-level
biological approaches. To date, the experimental and mod-
eling approaches at the heart of systems biology have largely
been examined in relatively simple experimental contexts that
are readily and repeatedly addressable, such as mammalian
cell lines in 2D culture. To enhance the prospects for systems
biology to bring about insight into the complex cellular
processes underlying human physiology and disease, and to
identify and validate candidate therapeutic approaches, it
needs to be advanced into improved experimental contexts
that more effectively represent the complexity and function-
ality of native tissues. Herein, we discuss how systems biology
can be adapted to the experimental constraints and interests
of tissue engineering, and suggest how systems biology could
aid in designing and investigating engineered tissue models for
the study of human physiology and pathophysiology.
Keywords—Tissue arrays, Multivariate measurement, Partial
least-squares regression, Decision trees, Bayesian networks.
INTRODUCTION
Tissue engineering is a biotechnology centered on
developing materials, scaﬀolds, or devices that provide
biochemical and biophysical cues to facilitate cell sur-
vival, proliferation, diﬀerentiation, and organization
into functional three-dimensional (3D) tissues.19 The
ﬁeld of tissue engineering began decades ago with a
focus on in vivo therapeutic constructs, but has pro-
gressed to now include a substantial emphasis on the
likely greater impact of providing more effective
experimental systems for studying complex human
tissue physiology and pathophysiology in vitro.20 This
direction emerged in part because animal models fail to
capture many crucial facets of human physiology,
notably in the areas of tissue-speciﬁc transcriptional
regulation,51 drug-induced liver toxicity,60 pathogenic
infection, host immune responses, and cancer.56,66
Further, though human cells cultured in standard
formats can be adapted to high-throughput assays,
most scalable cell cultures lack physiologically relevant
microenvironmental stimuli of native tissues. Engi-
neered tissues built with human cells are thus being
developed for a range of application areas, including
hepatic drug metabolism and toxicity,37,45,60 mammary
gland morphogenesis and oncogenesis,8,53 lymphoid
tissue neogenesis,26,63 and stem cell differentiation,12
and offer promise for scaling to the data collection
demands of high-throughput screening and systems
biology.
In tissues, individual cells are stimulated by a diverse
set of microenvironmental cues that arise from adhesion
to extracellular matrix (ECM) components, mechanical
forces, and soluble signaling factors from adjacent and
distant cells.20 Together, these cues activate a system of
cell signaling pathways whose integrated operation
regulates cell behavioral phenotypes.16 Resultant cell
behaviors are dependent not only on which microenvi-
ronmental cues are present, but also on their quantita-
tive amounts, spatial arrangements, and temporal
sequences. A central challenge in tissue engineering is to
elicit and maintain desired cell behaviors through
externally-applied and -induced chemical signals and
mechanical forces in a predictable fashion. A tremen-
dous diversity of tools—including biomaterials, biore-
actors, and microfabricated devices—have been
developed to manipulate tissue microenvironments.20,36
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Design principles for deploying these tools are likewise
emerging, but they are primarily aimed at relating the
magnitude of select external cues directly to cell phe-
notypic behaviors through quantitative analysis of
molecular diffusion, convection, reaction, binding, and
consumption.20,22 In increasingly complex engineered
microenvironments, detailed understanding of how the
multitude of cell signaling pathways process various
microenvironmental cues to govern their behaviors will
require application of systems-level approaches. To this
end, systems biology offers a powerful new tool for the
design and analysis of engineered tissues.
Systems biology seeks a deep quantitative under-
standing of complex biological processes through the
integration of multivariate molecular-level measure-
ment and modeling approaches, and thus diﬀers from
proteomic and genomic eﬀorts that aim to catalogue a
broad listing of biological components and their
functions.1,25 Advances in high-throughput and mul-
tiplex techniques for quantifying the abundances and
activities of the molecular components involved in
gene expression,38 metabolism,50 and signal transduc-
tion1 make it feasible to collect large data sets of
diverse cellular processes. Large-scale quantitative
studies of complex biomolecular processes are difﬁcult
to interpret by inspection and intuition alone. Com-
putational modeling allows simpliﬁcation of large-scale
biological data sets and can suggest mechanistic
insights and enable quantitative predictions of cellular
processes.25,31
Our review here focuses on molecular-level models
that attempt to relate microenvironment stimuli to
intracellular signal transduction pathways and their
regulation of cellular behavioral responses. For dis-
cussion of systems-level modeling of transcription and
metabolism, readers are referred to other reviews.33,50
Although some promising systems-level studies5,12,39,62
have been examined in contexts that capture some of
the physiological complexity of native tissues, systems-
level cell signaling–response measurements and mod-
els, to date, have been largely implemented in simple,
‘‘prototypical’’ experimental contexts. In this review,
we discuss how systems biology might be more fully
integrated into the design and analysis of engineered
tissues. A schematic illustration of the key facets of our
address is provided in Fig. 1.
SYSTEM-LEVEL MEASUREMENT OF CELL
SIGNALING AND BEHAVIORAL PHENOTYPES
In systems biology, the collection of experimental
data sets is organized and conducted with regard to
intended modeling eﬀorts and practical limitations.
Systems models largely require dynamic, highly
multivariate, and quantitative data of protein activities
and cell behavioral phenotypes collected in speciﬁc cell
types subjected to deﬁned, and often diverse, stimuli. A
wide variety of high-throughput and multiplex experi-
mental techniques are utilized to collect data sets for
systems models. These include mass spectrometry,67
kinase activity assays,28,59 immunoblotting,14 ‘in-cell
westerns’,41 bead-based arrays,48 protein microarrays,40,58
and multicolor ﬂow54,57 and image11,46 cytometry.
In selecting appropriate measurement techniques,
one often considers the identity and number of
simultaneously measurable signals (whether assays can
be ‘multiplexed’), the amount of sample required per
assay, and whether single-cell or population-level
behavior is measured.1 Mass spectrometry can be used
to quantify the relative abundance of hundreds of
FIGURE 1. The scope of measurement and modeling in
systems biology and tissue engineering. The present and
future implementation of systems biology and tissue engi-
neering are depicted with respect to: biological context
(ranging from prototypical cell lines to engineered and native
tissues to whole organisms); modeling detail (ranging from
statistical models to influence models to mechanistic mod-
els); and molecular detail (ranging from a single protein to the
entire proteome). To date, tissue engineering has been
focused on the recapitulation of the physiological complexity
of native tissues but has not been studied in great molecular
detail nor has been fused with systems-level computational
modeling efforts. In contrast, systems-level computational
models, such as partial least-squares regression (PLSR),
decision trees (DT), Bayesian networks (BN), and physico-
chemical (PC) models, can interpret a variety of molecular
relationships governing cellular behavior but have been
studied largely in a prototypical biological context (e.g., cell
lines). Future fusion of tissue engineering and system biology
will require adaption of tissue engineering to the measure-
ment demands systems-level computational models. Consid-
ering these demands, PLSR, DT, and Bayesian models
provide attractive candidates for analysis of cell behaviors
within engineered tissues in the near future. More substantial
progress in tissue engineering and multivariate measurement
technologies will be required for implementation of models
with more mechanistic and molecular detail.
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regulatory protein phosphorylation sites across multi-
ple biological samples, but requires 105–107 cells per
sample due to the fractionation required to detect low
abundance peptides in a complex cellular lysate.71
Kinase activity assays directly measure the enzymatic
activity of kinases to phosphorylate substrates via
radiochemical28 or ﬂuorescence59 readouts and are
multiplexible but require ~105 cells per kinase assayed.
‘In-cell westerns’ are a form of immunoﬂuorescence
microscopy that measures protein levels or states in
ﬁxed cells still adherent to culture surfaces;41 this
method is not currently multiplexible but requires only
104–105 cells per protein assayed. Bead-based arrays
utilize ﬂow cytometric quantiﬁcation of bead-conju-
gated, ﬂuorescently labeled antibody sandwich
assays.48 A number of commercial vendors provide
well-validated, highly multiplexible reagents for phos-
phoprotein quantiﬁcation in a cell lysate using the
Luminex platform. In practical applications, ~10–20
phosphoproteins can be quantiﬁed in a lysate from
104–105 cells. Protein microarrays allow detection of
binding avidities of cellular proteins to hundreds of
printed protein and/or substrate features and can be
conducted with a lysate from 104 to 105 cells.58 Mul-
ticolor ﬂow and image cytometry can assess phos-
phoprotein levels and cellular phenotypes (such as
proliferation, apoptosis, and migration) at a single-cell
level. Using well-validated antibodies and stains, mul-
tiplexing ~10 and ~4 parallel measurements are typical
current practical upper limits for ﬂow54 and image46
cytometry, respectively, but informative data sets can
be collected in as few as 102–103 cells per condition.
As no individual measurement technique can cap-
ture the full diversity of protein signals important to
the operation of cell signaling networks, systems biol-
ogy models of cell signaling and responses are
increasingly relying on data compendia assembled
from heterogeneous assay types.14 Assembly of such
data compendia requires careful consideration to data
fusion, normalization, and scaling when applied to
quantitative models. Readers are referred elsewhere1,14
for discussions of data compendia assembly and vali-
dation.
DATA-DRIVEN MODELING OF CELL
SIGNALING AND BEHAVIORAL PHENOTYPES
A wide spectrum of computational modeling
approaches for studying cell signaling and its regula-
tion of behavioral phenotypes is available.30 Because
the mechanisms connecting disparate cell signaling
pathways to each other and to integrated cell behaviors
are largely unknown, approaches such as differential
equation-based physicochemical models3 that require
substantial mechanistic knowledge are currently
limited in their practical applicability for analyzing
relationships between regulatory network activities
and downstream cell phenotypic behavior. Accord-
ingly, we focus here on a set of more abstract modeling
approaches more suitable for characterizing the oper-
ational relationships, inﬂuences, and logic of cell
signaling networks as they relate to cell functions:
partial least-squares regression (PLSR), decision trees,
and Bayesian network inference.
Partial Least-Squares Regression
Partial least-squares regression (PLSR) models are
based on the hypothesis that, across multiple treatment
conditions, cell behavioral phenotypes (‘responses’) are
inherently dependent on quantitative combinations of
a subset of measurable activities or states of key sig-
naling molecules (‘signals’).27,31 Measured signaling
variables (including both protein activities at multiple
time points and extracted time-dependent metrics) and
measured cell behaviors are cast into two separate data
matrices: an independent block of signaling variables
(X) and a dependent block of response variables (Y),
both arrayed across multiple cellular conditions. Since
the number of cellular conditions measured often is
exceeded by the number of signaling variables, PLSR is
necessary to calculate a unique regression solution to
the hypothesized relationship Y = f(X). PLSR iden-
tiﬁes a linear solution to the signaling–response rela-
tionship within a reduced-dimensionality data space
deﬁned by a set of orthogonal principal components.15
(It should be noted that nonlinear relationships can be
readily modeled through inclusion of nonlinear com-
binations of variables and/or variable transforma-
tions.) The calculation of principal components-based
regression weights is biased towards those signaling
variables that most strongly correlate with the
responses and to optimize prediction accuracy of the
responses in cross-validation.
PLSR models can be used to elucidate an integrative
model of network operation that can identify key
combinations of signaling activities governing mea-
sured cell behaviors. Moreover, they can be used to
quantitatively and accurately predict responses of cells
to additional treatments, such as pharmacologic per-
turbations, a priori using newly measured and/or esti-
mated signaling data. To generate a model capable of
accurate a priori predictions, the conditions used to
train a PLSR model need to strongly and differently
activate the breadth of measured cell signaling activi-
ties and behaviors.14,47 PLSR models have been gen-
erated using cell signaling and response data from a
number of the aforementioned measurement tech-
niques, and have been successful at interpreting and
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predicting cell signaling–response relationships in var-
ied contexts such as ECM-regulated embryonic stem
cell self-renewal and differentiation,55 cytokine- and
pathogen-induced epithelial cell apoptosis-sur-
vival,14,27,47 receptor agonist-induced T-cell and B-cell
cytokine release,34,43 and growth factor-induced
mammary epithelial cell proliferation and migration.44
Decision Trees
Decision tree (DT) models can be useful as network-
function models to interpret and predict cell signal–
response relationships in terms of logical combinations
of multiple signal activity levels. Decision tree models
are generated from a learning algorithm that approx-
imates a cellular output by constructing a ‘‘tree’’ where
the ‘‘branches’’ classify logical combinations of signals
based on their measured or estimated levels, and the
‘‘leaves’’ at the end of the branches predict the cellular
output. The idea behind DT modeling is to recursively
split signal–response data into successively smaller
branches in order to end up with a tree in which signal
combination branches are obtained that can classify
response behavior as correctly as possible. A decision
tree model is usually obtained via a two-step pro-
cess.4,21 The ﬁrst step, tree growing, is done until all
response observations are classiﬁed correctly. The
second step, tree pruning, is done in order to avoid
over-ﬁtting. In generally, decision tree models have
several properties that are appealing in biomedical
research4: (a) they can be effectively applied to broad
classes of data, in particular to discrete, continuous or
mixed data; (b) they are capable of good prediction
accuracy for highly nonlinear prediction problems; (c)
their prediction rules are easy to visualize and inter-
pret; and (d) they are very robust against outliers.
Additionally, a DT model provides quantitative pre-
dictions to guide interventions, such as using phar-
macologic inhibitors, even when such interventions
only partially diminish the signal. Moreover, the DT
approach facilitates incorporation of nonlinear
behavior more readily through its alternative inclu-
sions of qualitatively diverse model branches charac-
terizing different logical relationships among the
signaling nodes. Successful decision tree models have
been developed for growth factor- and ECM-induced
ﬁbroblast migration21,35 and Fas-mediated T lym-
phoma apoptosis.23
Bayesian Networks
Bayesian networks oﬀer a modeling technique for
identifying causal relationships among multiple sig-
nals as well as from signals to responses. Bayesian
network models illustrate the interactions of pathway
components in the form of inﬂuence diagrams that
can contain both direct molecular interactions (e.g.,
kinase-substrate phosphorylation) and indirect inﬂu-
ences that proceed through unobserved intermedi-
ates.57 Models are inferred through probabilistic
calculations of covariations in activities of multiple
signaling species, usually sparsely distributed across
different signaling pathways, collected from single
cells57 or populations of cells68 exposed to diverse
combinations of extracellular stimuli and genetic an-
d/or pharmacologic pathway interventions, with
effective inference requiring many observations. As
such, ﬂow cytometry data containing simultaneous
measurement of multiple phosphoproteins of thou-
sands of individual cells under a variety of treatment
conditions are well-suited for Bayesian inference and
have resulted in accurately inferred inﬂuence net-
works.57 In comparison, Bayesian models based on
population-based multivariate signaling data57,68
require more diverse treatments and have reduced
network inference accuracy, in part due to the obfus-
cation of informative heterogeneity at the single-cell
level. Inferred inﬂuence networks can suggest novel
signal transduction hypotheses57 but also could be
useful in identifying context-speciﬁc signaling network
structures. This kind of model can also be used to
make predictions about how interventions in the net-
work inﬂuence downstream cell phenotypic behaviors,
as demonstrated for the example of embryonic stem
cell self-renewal and differentiation responses to com-
binations of cytokine and extracellular matrix cues.68
We should emphasize that Bayesian network modeling
efforts to date have been restricted to static models,
but the feedback loops inherent in cell signaling
networks will likely often require dynamic Bayesian
network models adapted to handle cyclic connectivi-
ties.6
FUSING TISSUE ENGINEERING AND
MULTIVARIATE MEASUREMENT METHODS
Systems-level models require experimental data of
activities of multiple cell signaling molecules and behav-
ioral phenotypes across a diverse combination of treat-
ments, perturbations, and time points. Accordingly, they
require cell culture systems that are both addressable in a
high-throughput manner and amenable to multivariate
measurement methods. Recent advances oﬀer promise
for parallelizing the culture of microenvironmentally
complex engineered tissues (in so-called ‘multicellular
arrays’ or ‘tissue arrays’) suﬃcient to meet the data
demands of systems biology. Culture arrays have
risen out of the desire to screen phenotypes of multicel-
lular structures in a high-throughput manner, and
have been applied to drug discovery64 and toxicology45
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and combinatorial approaches to directing and main-
taining cell differentiation.13,18,62,65 Such combinato-
rial screens of cell differentiation have provided
unexpected insights into relationships between multiple
microenvironmental cues13 (e.g., printed ECM ligands)
or intracellular signals55,62 and the maintenance of
differentiated phenotypes through multiparameter
analyses. (Note that we refer to culture arrays with
~102–103 cells per spot or well as ‘tissue microarrays’
and those with ~105–106 cells per sample well as
‘multiwell-format tissue arrays’.)
We wish to emphasize that systems biology models
to date have focused on responses to ‘‘acute,’’ bolus
administration of cytokines and growth factors and
thus have inferred substantial predictive signiﬁcance to
the transient signals and derived time course metrics
immediately following receptor activation.14 However,
in tissue engineered constructs as in physiological
contexts, most cell behaviors more likely are governed
by longer time-scale stimuli, under more ‘‘chronic,’’
quasi-steady-state conditions. There might indeed be
signiﬁcant differences in relationships between cues,
signals, and responses for chronic as opposed to acute
cue treatment, as in a recent report of important
pathophysiological differences in 2D mammary
epithelial migration by autocrine ligands or bolus
stimulation from exogenously-added ligand.32
Tissue Microarrays
Eﬀorts in developing tissue microarrays have
been focused on validating consistency of cellular
phenotypes and assays such as drug-induced hepa-
tocyte toxicity,45,52 stem cell differentiation,18 and
epithelial tissue organization,2,61 and have not been
used to systematically examine cue- or signal–
response relationships. A tissue microarray system
well-suited for systems biology approaches is that of
mammary epithelial cells in microprinted Matrigel
cultures.61 Matrigel culture of mammary epithelial
cells fosters the establishment of 3D multicellular
structures that resemble in vivo mammary gland
acini, with the development epithelial cell structures
that resemble either normal or cancerous mammary
acini depending on a well-documented variety of
both microenvironmental cues (such as matrix
mechanical stiffness and composition and growth
factor stimulation) and oncogenic perturba-
tions.7,8,53,69 As of yet, tissue arrays have not been
adapted to allow inclusion of ECM components
with a combinatorial complexity matching that used
in the 2D microprinting methods13 which will be
necessary for systematic investigation of cellular
cue–signal–response relationships.
Although tissue microarrays could be scaled to be
amenable to lysate-based measurements (requiring
~105 cells), they are nonetheless appropriate for sys-
tems biology approaches, such as Bayesian network
inference, that are based on data from single cells or
small populations of cells examined over a multitude
of conditions. Critical will be the adaption of single-
cell multivariate measurement techniques of ﬂow and
image cytometry for use in 3D engineered tissues.
Multicolor ﬂow cytometry for quantifying multiple
phosphoproteins has been carefully validated54 and
implemented42,57 for non-adherent cells but not
adherent cells. Multicolor ﬂow cytometry in adherent
cells, especially from intact 3D tissues, is a signiﬁcant
challenge as single-cell isolation methods can elicit
stress-related signaling themselves and thus disturb
signaling network states. Further, prolonged isolation
requirements could restrict the ability to measure the
highly-informative phosphorylation events that follow
within minutes of cell stimulation. In contrast, image
cytometry does not require isolation and permits for
immediate cell ﬁxation, allowing for sufﬁcient tem-
poral resolution to measure immediate phosphoryla-
tion events. Instead, it is currently limited in its ability
to include more than ~4 simultaneous single-cell
measurements due technical constraints.46 Multicolor
3D imaging (so-called ‘tissue cytometry’11) using
confocal microscopy is not yet sufﬁciently high-
throughput to capture multivariate single-cell data
across hundreds of tissue samples in an automated
fashion. Improvements in 3D imaging with respect to
these limitations could make it a highly attractive
approach for system-level, single-cell data acquisition,
especially in the context of engineered tissues, such as
immunological synapse arrays,9 whose cellular
behaviors are dependent on microscale patterning of
stimulatory cues thus necessitate spatially-resolved
single-cell data.
Immunoﬂuorescence methods, such as in-cell west-
erns, which are reasonably high-throughput but not
strictly multiplexible, could be used to measure phos-
phoprotein levels or cell phenotypes in small popula-
tions of cells (~102–103) within tissue microarrays.
In-cell western measurements of arrayed tissues over a
large combination of treatment conditions, assay tar-
gets, and, likely, sample replicates could yield a data
set sufﬁcient for Bayesian models. As in-cell western
measurements are not multiplexible, multivariate data
sets will require assembly from multiple independent
samples of cells, thus obscuring the single-cell covari-
ations of signaling activities that are particularly
informative in Bayesian models.57 Consequently, a
substantial set of microenvironmental stimuli combi-
nations (~100) might be required for accurate Bayesian
network inference. Moreover, care must be taken to
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insure that the biological heterogeneity, due to the
small number of cells per sample, and measurement
inaccuracy, which often arises due to the restrictive
dynamic range of in-cell westerns, does not confound
multivariate measurement fusion. A correlated, and
promising, method called ‘‘stochastic sampling’’
employs laser-capture microdissection and a custom-
ized quantitative PCR method to perform multiplexed
gene expression proﬁling in small populations of cells
(~10) has lead to novel insights into the regulation of
transcription programs controlling heterogeneous cell
behaviors in 3D mammary acini cultures.29
Multiwell-Format Tissue Arrays
Multiwell-format tissue arrays10,60 are based on
12- or 24-well culture formats and can accommodate
~105–106 cells per sample well (sufﬁcient for lysate-
based measurements) and be scaled to a moderate
number of sample conditions (i.e., treatments, time
points) and thus are suitable for a greater diversity of
systems-level modeling approaches than tissue micro-
arrays. A well-developed example of these multiwell-
format tissue arrays that utilizes a 3D microenviron-
ment is a perfused liver cell microreactor.10,60 Perfused
microreactors foster the maintenance of in vivo-like
function of primary hepatocytes60 and/or liver sinu-
soidal endothelial cells24 over a prolonged culture
duration (~14 days) in a physiologically-relevant 3D
microenvironment. And, as such, have been used
examine hepatic drug metabolism and enzyme induc-
tion60 and sinusoidal morphogenesis24 over physiolog-
ically-relevant time scales.
The larger cell numbers per sample permit lysate
methods such as bead-based arrays48 and multiplexed
kinase activity assays28 to be utilized in addition to
multicolor ﬂow and image cytometry (given the afore-
mentioned improvements) to measure cell signaling
activities and phenotypes in a multivariate manner.
Bead-based phosphoprotein arrays allow for a greater
number of measureable signaling molecules as they are
beneﬁted by an expansive set of validated, multiplexible
reagents, while kinase activity assays have the advantage
ofmeasuring signal transduction activity directly, rather
than inferred via phosphorylation state. Consequently,
activity data fromkinases, especially of those thought to
be at nodes of signaling networks that integrate multiple
pathways, are often found to be highly informative sig-
nals in PLSR cell signaling–response models trained on
protein signaling data from heterogeneous assays.14,27
Practical limitations on cell material and knowledge of
which protein signaling assays have been informative
previously14 together suggest that PLSR models using
multiwell-format tissue arrays might be best con-
structed using ~2–3 kinase assays and ~10 bead-based
phosphoprotein measurements (all from a single lysate)
of proteins distributed across multiple cell signaling
pathways. A challenge in multivariate measurement of
engineered liver cell co-cultures (usually containing
hepatocytes and second liver cell type) is the correct
attribution of signaling proﬁles to each of the multiple
cell types present. Flow cytometry methods can simply
employ one staining channel to a cell type marker, but
lysate based methods require less straight-forward
approaches such as those that rely on biomolecular
mixture models17 to infer cell type-speciﬁc phospho-
protein proﬁles.
IMPLEMENTING SYSTEMS-LEVEL MODELING
TO THE DESIGN AND ANALYSIS OF
ENGINEERED TISSUES
In contrast to the ﬁelds of genomics and proteomics,
a systems biology approach insists that knowledge and
understanding about biology resides not in databases
but instead in models—and that given the complexity
of multivariate experimental measurements these
models must be computational in nature. Thus, the
data generated in tissue engineering contexts as dis-
cussed in the previous section will be most gainfully
employed by analysis in terms of one or more of the
data-driven modeling methods described earlier.
Data-driven models of dynamic, multivariate cell
signaling and response data can suggest hypotheses
that relate activities of signaling molecules to behav-
ioral phenotypes and can be implemented to generate
a priori predictions of responses to new signaling net-
work proﬁles. Such models are most effectively con-
structed on the basis of training across a broad
landscape of conditions, including conﬂicting or
antagonizing cues, that stimulate a diversity of sig-
naling network activities and cell responses that might
be hypothesized to comprehend a range of physiolog-
ical phenotypic behaviors.27,34,44,47 Prediction of cell
behavior can then be effectively interpolative rather
than extrapolative. A priori prediction of cell pheno-
types based on signaling network states could lead to
the identiﬁcation nonintuitive combinations to signal-
ing activities (through computation searches, for
example) that optimally produce a desired cell phe-
notype in an engineered tissue. Design of novel engi-
neered tissue microenvironments that generate the
optimal signaling network state could be furthermore
governed by physicochemical models of receptor acti-
vation and downstream signaling, thus integrating
mechanistic and data-driven model approaches23 to
design features for fostering desired tissue phenotypes.
Moreover, models of cell behavior within a tissue
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engineered to mimic a particular physiology or
pathophysiology could yield models capable of pre-
dictions of drug efﬁcacy and toxicity in physiologically
relevant, tissue-speciﬁc contexts. In particular, such
approaches could be used to select target pathways for
interfering with 3D cell migration behaviors critical to
cancer metastsis70 and matrix stiffness-induced mam-
mary acinar oncogenesis.7,53 For instance, successful
a priori PLSR model prediction of cell phenotypic
changes due to perturbation by one or more small
molecular inhibitor(s) has been veriﬁed for compounds
with speciﬁed kinase targets that lie upstream of pro-
tein signal(s) contained in the model and implemented
by ‘computationally inhibiting’ only the measured
signals in a subset of the training data and then com-
paring the predicted results to new experiment obser-
vations.34,47 Perturbations that affect signaling
networks more globally (therefore less predictably)
such as growth factor receptor overexpression,43 dis-
ruption of autocrine ligand signaling,27 and RNA
interference43 have been evaluated using complete
re-collection of signaling data rather than the
straightforward estimation methods successful for
small molecular inhibitors. When measuring multiple
diverse kinds of cell phenotypic behaviors, as is desired
for understanding complex tissue physiology, con-
structing separate submodels for the various behaviors
might allow for easier interpretation of the various
respective signaling–response relationships.
Decision tree and Bayesian network models can
extend predictive capabilities to causality, more
strongly indicating molecular mechanisms. For exam-
ple, a Bayesian network model for the signaling net-
work regulating diﬀerentiation versus self-renewal
processes of mouse embryonic stem cells permitted
experimentally validated prediction of eﬀects of Raf1
independent of the canonical Raf-MEK-ERK path-
way.68 Analogously, one can envision developing a
similar predictive capability for signals governing
lineage speciﬁcation of mesenchymal stem cells cul-
tured in complex 3D microenvironments containing
varying adhesion ligands, matrix rigidities, and growth
factors.12 Likewise, predicted signaling network inﬂu-
ences could suggest microenvironmental cue and
pharmacological intervention combinations for inﬂu-
encing osteoblast speciﬁcation for implantable bone
regeneration therapies.49
Moreover, Bayesian network inference approaches
could ask fundamental questions about the perhaps
subtle diﬀerences in signaling network structure and
function in cells of varying lineages and disease states
and how those networks diverge from canonical
models.42 Such understanding could drive clinical
therapies that are motivated by context-speciﬁc cell
signaling networks. Bayesian approaches could be
employed in the challenging task of investigating the
crosstalk between multiple cell types in healthy or
diseased tissues. By engineering tissue arrays that
contain multiple interacting cell types, such as the
immune system cells within a lymph node26 or the
varied cells within the liver,24 and measuring both cell
type-speciﬁc phosphoprotein signaling and levels of
soluble or matrix-related signaling factors, Bayesian
network inference models can be constructed to pro-
vide mechanistic hypotheses for complex cellular
crosstalk in tissues.
CONCLUDING NOTE
The ﬁelds of tissue engineering and systems biology
have each been motivated by an aspiration to generate
more physiologically relevant approaches to under-
standing and manipulating biology, with the former
focusing on improved experimental contexts while the
latter has focused on enhanced experimental mea-
surements and computational modeling techniques. It
is clearly manifest at this point in time that each of
these ﬁelds needs to become intimately fused with the
other in order to fulﬁll their shared vision and promise.
We hope that this article will be useful to many
investigators, in academic as well as industrial research
endeavors, to be encouraged to consider their inte-
gration as a high priority.
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